Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease

dc.date.accessioned	2020-10-21T06:46:08Z
dc.date.available	2020-10-21T06:46:08Z
dc.date.issued	2015
dc.date.issued	2014/12/20
dc.identifier.citation	Acikgoz SB, Yildirim M.,.Clin Drug Investig. 2015 Feb;35(2):149. doi: 10.1007/s40261-014-0262-6.
dc.identifier.uri	http://doi.org/10.1007/s40261-014-0262-6
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71792
dc.description	PMID = 25523130
dc.relation.isversionof	10.1007/s40261-014-0262-6
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease
dc.type	article
dc.relation.journal	Clin Drug Investig
dc.identifier.doi	10.1007/s40261-014-0262-6
dc.contributor.author	Solak Y
dc.contributor.author	Acikgoz SB
dc.contributor.author	Yildirim M.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi